Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

513.12
-7.8800-1.51%
Post-market: 513.310.1900+0.04%19:30 EDT
Volume:415.57K
Turnover:215.18M
Market Cap:22.01B
PE:18.36
High:528.02
Open:523.23
Low:512.29
Close:521.00
52wk High:609.35
52wk Low:302.19
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.96
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.44
PE(LYR):18.42

Loading ...

United Therapeutics Corp - Appoints Victor Dzau to Board of Directors on July 22, 2026

THOMSON REUTERS
·
Jul 23

Press Release: United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026

Dow Jones
·
Jul 22

United Therapeutics Updates Financial Calendar Ahead of Quarterly Results Release, Webcast

Reuters
·
Jul 22

United Therapeutics Chairperson, CEO Martine Rothblatt Reports Sale of 9,500 Shares for $5.03 Million

Reuters
·
Jul 22

Julien Nono-Womdim’s Top Picks for July 21, 2026

Bloomberg
·
Jul 22

United Therapeutics Corp : Leerink Partners Cuts Target Price to $695 from $700

THOMSON REUTERS
·
Jul 21

United Therapeutics CEO Martine Rothblatt Reports $ 4.45 Million Common Share Disposal

Reuters
·
Jul 21

United Therapeutics CEO Martine Rothblatt Reports UTHR Common Share Sale Worth $4.97 Million

Reuters
·
Jul 18

United Therapeutics (UTHR) Stock Still Looks Like A Bargain After A 185% Run

Simply Wall St.
·
Jul 18

United Therapeutics EVP, General Counsel Paul A. Mahon Disposes of Common Shares Worth $3.97 Million

Reuters
·
Jul 17

United Therapeutics CEO Martine Rothblatt Disposes of 9,500 Shares for $5,008,396.54

Reuters
·
Jul 16

United Therapeutics Chairperson, CEO Martine Rothblatt Sells USD 4.89 Million in Common Shares

Reuters
·
Jul 15

United Therapeutics CEO Martine Rothblatt Disposes of USD 3.29 Million in Common Shares

Reuters
·
Jul 14

United Therapeutics Director Jan Malcolm Sells 325 Shares for $178,941.75

Reuters
·
Jul 11

United Therapeutics is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 11

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

BETA Technologies Completes First FAA Evtol Integration Pilot Flights Carrying Manufactured Organs

Reuters
·
Jul 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

BofA Securities Adjusts United Therapeutics Price Target to $613 From $620

MT Newswires Live
·
Jul 10

United Therapeutics price target lowered to $613 from $620 at BofA

TIPRANKS
·
Jul 10